2023. Blood glucose related adverse drug reaction of antitumor monoclonal antibodies: a retrospective analysis using Vigibase. Brazilian Journal of Pharmaceutical Sciences. 59, (Apr. 2023), e18893. DOI:https://doi.org/10.1590/s2175-97902020000118893.